Shionogi & Co.,Ltd. (4507) Balance sheet

Market cap

¥2.47T

P/E ratio

11.3x

Develops, manufactures and sells prescription pharmaceuticals globally, specializing in infectious diseases and central nervous system disorders.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Cash and cash equivalents	-	50,784	80,230	107,847	140,106	193,549	208,861	276,173	254,420	309,224	358,090	374,795	711,397
Marketable securities, current	-	58,700	97,200	98,800	124,300	133,264	171,157	142,151	210,757	254,131	215,761	270,024	310,748
Accounts receivable, net	-	70,584	65,207	59,336	53,240	65,918	-	-	-	-	-	-	-
Inventories	-	18,943	21,263	19,152	14,716	18,741	33,818	38,003	45,892	57,919	64,916	65,477	99,396
Total current assets	-	259,948	315,611	343,384	391,266	461,743	516,026	556,238	659,205	784,192	784,205	858,504	1,310,335
Property, plant and equipment, net	-	77,022	78,673	78,788	75,956	74,653	71,350	90,883	108,893	112,085	114,586	115,412	156,519
Marketable securities, non-current	-	158,339	146,451	135,970	155,675	151,851	202,161	217,437	242,479	247,711	292,321	299,799	107,518
Total non-current assets	-	342,951	324,027	326,886	331,233	316,997	355,500	442,754	491,396	527,607	632,712	676,844	1,266,535
Total assets	-	602,900	639,638	670,271	857,725	938,540	871,526	998,992	1,150,601	1,311,800	1,416,918	1,535,349	2,576,870
Accounts payable	-	11,572	11,050	11,943	8,016	9,442	-	-	-	-	-	-	-
Short-term debt	-	-	-	-	10,470	17,008	17,557	21,383	22,027	29,720	31,118	18,091	40,716
Long-term debt, current	-	38	-	-	10,000	918	-	-	-	-	-	-	660,000
Total current liabilities	-	67,794	71,982	90,595	72,566	89,107	81,119	100,180	124,396	158,552	133,907	129,392	827,430
Long-term debt, non-current	-	-	-	-	22,595	6,006	4,791	4,608	35,913	39,513	8,753	18,418	18,895
Total non-current liabilities	-	56,222	53,778	53,464	45,092	17,203	25,795	34,261	32,920	31,369	30,448	43,459	63,235
Total liabilities	-	124,016	125,761	144,059	122,910	125,452	106,915	134,442	157,316	189,921	164,355	172,852	890,665
Retained earnings	-	455,497	503,946	508,049	574,392	639,461	708,291	752,248	832,958	940,606	1,065,913	1,115,729	1,492,697
Stockholders' equity	467,836	478,883	513,877	526,211	604,840	672,429	764,611	864,550	993,285	1,121,878	1,252,562	1,362,497	880,509
Working capital	-						-	-	-	-	-	-	-